Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02LXJ
|
||||
Former ID |
DNC007083
|
||||
Drug Name |
3-(2-cinnamylphenyl)acrylic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528393] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H16O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O
|
||||
InChI |
1S/C18H16O2/c19-18(20)14-13-17-11-5-4-10-16(17)12-6-9-15-7-2-1-3-8-15/h1-11,13-14H,12H2,(H,19,20)/b9-6+,14-13+
|
||||
InChIKey |
LDBYEQVSQBZSEH-BDXQXIFWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin E2receptor, EP2 subtype | Target Info | Inhibitor | [528393] | |
Prostaglandin E2 receptor EP3 subtype | Target Info | Inhibitor | [528393] | ||
Prostaglandin E2 receptor, EP4 subtype | Target Info | Inhibitor | [528393] | ||
KEGG Pathway | cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Inflammatory mediator regulation of TRP channels | |||||
Renin secretion | |||||
Pathways in cancerhsa04020:Calcium signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Pathways in cancerhsa04080:Neuroactive ligand-receptor interaction | |||||
Pathways in cancer | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.